World's first malaria vaccine clears EMA hurdle
This article was originally published in SRA
Executive Summary
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended for approval the world's first vaccine for malaria1,2.
You may also be interested in...
GSK Malaria Vaccine Gets Landmark Clearance For Use In Africa
Mosquirix is set for much wider availability in sub-Saharan Africa thanks to positive results from a pilot program in Ghana, Kenya and Malawi. The next step is deciding how to fund the vaccine’s rollout over the coming years.
UK Reimbursement Decisions Focus Mostly On Cancer
The UK's main reimbursement bodies made a series of decisions this week that were broadly favorable and largely focused on oncology medicines.
Deal Watch: Valeant Sells Off iNova To Finance Debt-Reduction Efforts
While troubled Valeant was divesting iNova to private equity investors, Novartis announced a pair of oncology-focused deals, out-licensing a brain cancer drug to Midatech and partnering with IBM Watson Health to optimize breast cancer treatment.